Kimberly Stegmaier, MD: Pediatric Hematology Malignancy Program | Dana-Farber Cancer Institute
1,425 views · Published 3 December 2014 · 10:11 · Indexed 20 October 2026
Channel: Dana-Farber Cancer Institute · 2014 · Science & Technology
Kimberly Stegmaier, MD, Co-Director of the Pediatric Hematologic Malignancy Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, gave an update at our Joint Visiting Committee Symposium on her research aimed at finding new drug targets and developing new drugs for pediatric patients.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute